(Q42224380)

19 October 2017

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications (English)

1 reference

19 October 2017

0 references

1

1 reference

19 October 2017

4

1 reference

19 October 2017

3

Frank B Hu

1 reference

19 October 2017

2

Hans-Ulrich Häring

1 reference

PubMed ID

24622321

19 October 2017

language of work or name

1 reference

30 August 2013

1 reference

The Lancet: Diabetes & Endocrinology

19 October 2017

1 reference

19 October 2017

1

1 reference

19 October 2017

2

1 reference

19 October 2017

152-162

1 reference

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Adiposity as Compared with Physical Activity in Predicting Mortality among Women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Global obesity: trends, risk factors and policy implications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

General and Abdominal Adiposity and Risk of Death in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Global trends in body-mass index

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Identification and characterization of metabolically benign obesity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Metabolic and body composition factors in subgroups of obesity: what do we know?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Are there persons who are obese, but metabolically healthy?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Insulin signalling and the regulation of glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Waist circumference as compared with body-mass index in predicting mortality from specific causes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

All-cause mortality risk of metabolically healthy obese individuals in NHANES III.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Cardiorespiratory fitness and adiposity as mortality predictors in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Cardiorespiratory fitness, adiposity, and all-cause mortality in women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Letter by Stefan et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men".

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Obesity-associated improvements in metabolic profile through expansion of adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Clinical review#: Lipodystrophies: genetic and acquired body fat disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

'Metabolically healthy obesity': origins and implications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Insulin-sensitive obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

The impact of liver fat vs visceral fat in determining categories of prediabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

The metabolically benign and malignant fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

The role of hepatokines in metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Thiazolidinediones and PPARγ agonists: time for a reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Metabolically healthy but obese women: effect of an energy-restricted diet

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Effects of a lifestyle intervention in metabolically benign and malign obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Effects of weight loss among metabolically healthy obese men and women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Health benefits of gastric bypass surgery after 6 years

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Clinical practice. Nonsurgical management of obesity in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Bariatric surgery and long-term cardiovascular events.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Inadequacy of BMI as an indicator for bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Soc

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

What is "metabolically healthy obesity"?: from epidemiology to pathophysiological insights

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970062-7

7 January 2021

10.1016/S2213-8587(13)70062-7

Identifiers

DOI

1 reference

19 October 2017

1 reference

PubMed ID

24622321